Recruiting Schizophrenia Studies in West Los Angeles
About Schizophrenia Clinical Trials in West Los Angeles
Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.
There are currently 1 schizophrenia clinical trials recruiting participants in West Los Angeles, CA. These studies are seeking a combined 50 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.
Schizophrenia Clinical Trials in West Los Angeles — FAQ
Are there schizophrenia clinical trials in West Los Angeles?
Yes, there are 1 schizophrenia clinical trials currently recruiting in West Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in West Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Los Angeles research site will contact you about next steps.
Are clinical trials in West Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Los Angeles studies also compensate for your time and travel.
What schizophrenia treatments are being tested?
The 1 active trials in West Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.
Data updated July 18, 2026 from ClinicalTrials.gov